BloodPAC
Cancer Moonshot - BloodPAC

About

BloodPAC

The Blood Profiling Atlas in Cancer (BloodPAC) Consortium was launched on October 17, 2016 to accelerate the development and validation of liquid biopsy assays to improve the outcomes of patients with cancer.

To do so BloodPAC will develop a collaborative infrastructure that enables sharing of information between stakeholders in industry, academia, and regulatory agencies.

BloodPAC is a consortium managed by the Center for Computational Science Research, Inc. (CCSR), which is an Illinois based not-for-profit corporation.


BloodPAC Mission

Our mandate is to accelerate the development and validation of liquid biopsy assays to improve the outcomes of patients with cancer. To do so, we will develop a collaborative infrastructure that enables sharing of information between stakeholders in the public, industry, academia, and regulatory agencies.

BloodPAC Vision

The BloodPAC consortium recognizes data sharing and evidence generation as the two fundamental requirements for success and is pursuing them through dedicated workstreams:

•Create BloodPAC Data Commons to serve the community at large for all liquid biopsy stakeholders

•Align around a framework for evidence generation to bring liquid biopsy into routine clinical practice

Get Involved

The BloodPAC consortium is committed to open and active membership and considers new applications on a rolling basis.   If you would like more information please contact us.  If you are interested in joining the BloodPAC you can find membership related materials here.

BloodPAC Leadership

Lauren Leiman; Executive Director, BloodPAC Consortium

Working Groups


Data

The Data working group provides a secure and compliant data commons to store, harmonize, and analyze blood profiling data submitted by the member organizations.


Technology Applications

The Technology Applications working group analyzes the tools used to collect and convert blood profiling samples into datasets.


Sample

The Sample working group is developing essential standards for the collection of blood profiling samples to accelerate the pace of discovery for the community. 


 

  • Kelli Bramlett - Thermo Fisher Scientific

  • Darya Chudova - Guardant Health

  • Phil Febbo, Illumina

  • Robert L. Grossman - University of Chicago, Open Commons Consortium


Scientific Co-Chair Committee Members

  • Peter Kuhn - University of Southern California

  • Jerry Lee - University of Southern California

  • Anne-Marie Martin - Novartis


 

  • Howard Scher - Memorial Sloan Kettering Cancer Center

  • John Simmons - Personal Genome Diagnostics

  • Jake Vinson - Prostate Cancer Clinical Trials Consortium